Status:
COMPLETED
Arginine as an Adjuvant Treatment Against Tuberculosis
Lead Sponsor:
Linkoeping University
Collaborating Sponsors:
University of Gondar
Kalmar County Hospital
Conditions:
Tuberculosis
HIV
Eligibility:
All Genders
15-60 years
Phase:
NA
Brief Summary
The purpose of this study was to investigate if adjuvant treatment with arginine (the substrate for nitric oxide production) rich food supplements could improve clinical outcome in patients with smear...
Detailed Description
Tuberculosis (TB) is disease of increased global public health importance. Because of emerging multi drug resistance and the long treatment duration there is a need to optimize the current chemotherap...
Eligibility Criteria
Inclusion
- Informed and written consent to take part in the study
- Previously untreated and newly diagnosed smear positive Tb patients according to the WHO definitions
Exclusion
- Hospitalization
- Pregnancy
- Known allergy against peanuts
- Chronic or acute disease other than tuberculosis/HIV
Key Trial Info
Start Date :
February 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT00857402
Start Date
February 1 2004
End Date
December 1 2006
Last Update
March 6 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gondar University, DOTS-center
Gondar, Region 3, Ethiopia, Gondar, Ethiopia, P.o. box 106